Showing results (251-260 of 266) with videos related to
Sort By:
Pageof 27
Alimentary Pharmacology & Therapeutics|May 20, 2025
Volatomics for Diagnosis and Risk Stratification of MASLD: A Proof-Of-Concept StudyR Sinha, S L Gillespie, P Brinkman, et al.European Journal of Gastroenterology & Hepatology|August 25, 2000
An improved ex vivo method of primary porcine hepatocyte isolation for use in bioartificial liver systemsL J Nelson, P N Newsome, A F Howie, et al.Alimentary Pharmacology & Therapeutics|January 21, 2012
The sequential organ failure assessment (SOFA) score is prognostically superior to the model for end-stage liver disease (MELD) and MELD variants following paracetamol (acetaminophen) overdoseD G N Craig, T W D J Reid, E C Wright, et al.European Journal of Gastroenterology & Hepatology|November 1, 1995
Middle cerebral artery blood flow velocity in patients with cirrhosisJ F Dillon, J N Plevris, F C Wong, et al.Lancet (London, England)|November 22, 2001
Referral patterns and social deprivation in paracetamol-induced liver injury in ScotlandP N Newsome, A J Bathgate, N C Henderson, et al.Alimentary Pharmacology & Therapeutics|March 8, 2016
Differential visceral blood flow in the hyperdynamic circulation of patients with liver cirrhosisN C McAvoy, S Semple, J M J Richards, et al.Alimentary Pharmacology & Therapeutics|February 3, 2012
UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patientsP Ramachandran, A Fraser, K Agarwal, et al.Clinical Radiology|February 25, 2011
The use of ultrasound to diagnose hepatic steatosis in type 2 diabetes: intra- and interobserver variability and comparison with magnetic resonance spectroscopyR M Williamson, E Perry, S Glancy, et al.Journal of Viral Hepatitis|December 2, 2017
Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international studyM Alavi, N Z Janjua, M Chong, et al.Alimentary Pharmacology & Therapeutics|April 24, 2014
Review article: 2014 UK consensus guidelines - hepatitis C management and direct-acting anti-viral therapyM H Miller, K Agarwal, A Austin, et al.Pageof 27